
Triglimiprex 1mg/500mg/7.5mg Tablet
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Triglimiprex 1mg/500mg/7.5mg Tablet
Glimepiride-Metformin-Pioglitazone 1mg/500mg/7.5mg tablets offer combined action for effective blood glucose management in adults with type 2 diabetes. This triple-combination therapy complements diet and exercise to enhance glycemic control. It facilitates optimal insulin utilization, consequently reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Always take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in this case, omit the missed dose and resume the regular regimen. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping increases the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessments will be conducted before therapy commences. Limit alcohol consumption during treatment to mitigate potential side effects.
Uses of Triglimiprex 1mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Triglimiprex 1mg/500mg/7.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Triglimiprex 1mg/500mg/7.5mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.
Common Side effects of Triglimiprex 1mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimiprex 1mg/500mg/7.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Triglimiprex 1mg/500mg/7.5mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Triglimiprex 1mg/500mg/7.5mg Tablet works:
Triglimiprex 1mg/500mg/7.5mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts via three pathways: reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimiprex 1mg/500mg/7.5mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimiprex 1mg/500mg/7.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Triglimiprex 1mg/500mg/7.5mg tablets are likely incompatible. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by abnormally low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Triglimiprex 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Triglimiprex 1mg/500mg/7.5mg tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Triglimiprex 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Triglimiprex 1mg/500mg/7.5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Triglimiprex 1mg/500mg/7.5mg Tablet :
Should you forget a Triglimiprex 1mg/500mg/7.5mg Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimiprex 1mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
